Translation of "uses financing " (English → French) :

cash used in financing activities | net cash flows used in financing activities

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptom ...[+++]s, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

counsel on use of land, make recommendations on use of land | guide the use of land | advise on use of land | advising on land uses

back-up and recovery tools using, use back-up tools | use back-up and recovery software | use back-up and recovery tools | use recovery tools

resources | application of funds | uses of financing | uses of funds

extra-label drug use | extra label drug use | extralabel drug use | off label drug use | off-label drug use | extralabel use | extra label use | extra-label use | off label use | off-label use

receive appropriate permissions for recorded audiovisual example use | receiving appropriate permissions for use of recorded audiovisual examples | Gaining appropriate permissions for use of recorded audiovisual examples | receive appropriate permissions for use of recorded audiovisual examples

Definition: This category should be used to record the presence of psychological or behavioural influences thought to have played a major part in the etiology of physical disorders which can be classified to other chapters. Any resulting mental disturbances are usually mild, and often prolonged (such as worry, emotional conflict, apprehension) and do not of themselves justify the use of any of the categories in this chapter. | Psychological factors affecting physical conditions Examples of the use of this category are:asthma F54 and J45.- | dermatitis F54 and L23-L25 | gastric ulcer F54 and K25.- | mucous colitis F54 and K58.- | ulcerati ...[+++]ve colitis F54 and K51.- | urticaria F54 and L50.-

Definition: This category should be used when two or more psychoactive substances are known to be involved, but it is impossible to assess which substance is contributing most to the disorders. It should also be used when the exact identity of some or even all the psychoactive substances being used is uncertain or unknown, since many multiple drug users themselves often do not know the details of what they are taking. | misuse of drugs NOS

EUROPA - EU law and publications - EUR-Lex - EUR-Lex - 62016CA0676 - EN - Case C-676/16: Judgment of the Court (First Chamber) of 17 January 2018 (request for a preliminary ruling from the Nejvyšší správní soud — Czech Republic) — CORPORATE COMPANIES s.r.o. v Ministerstvo financí ČR (Reference for a preliminary ruling — Prevention of the use of the financial system for the purpose of money laundering and terrorist financing — Directive 2005/60/EC — Scope — Article 2(1), point 3(c) and Article 3, point 7(a) — Business activity of an unde ...[+++]rtaking consisting in the sale of companies already entered in the Register of Companies and formed solely for the purposes of sale — Sale by means of the transfer of the undertaking’s holding in the ready-made company) // Judgment of the Court (First Chamber) of 17 January 2018 (request for a preliminary ruling from the Nejvyšší správní soud — Czech Republic) — CORPORATE COMPANIES s.r.o. v Ministerstvo financí ČR // (Case C-676/16) - ( // ((Reference for a preliminary ruling - Prevention of the use of the financial system for the purpose of money laundering and terrorist financing - Directive 2005/60/EC - Scope - Article 2(1), point 3(c) and Article 3, point 7(a) - Business activity of an undertaking consisting in the sale of companies already entered in the Register of Companies and formed solely for the purposes of sale - Sale by means of the transfer of the undertaking’s holding in the ready-made company))

The future UN High-Level Panel on Finance and the High-Level Advisory Group on Climate Change Financing should explore how these sources can be effectively used for financing future climate actions, with public finance focusing on areas that cannot be adequately financed by the private sector or used to leverage private investments.

In case any such institution uses the resolution financing arrangement for any of such purposes, the resolution authority should be able to compare the risk profile of all other institutions covered by Article 45(3) of Directive 2014/59/EU with that of the institution which used the resolution financing arrangement and apply the methodology set out this Delegated Act to those institutions which present a risk profile similar or higher than that of the institutions which used the resolution financing arrangement.

(d) All other currencies received by the Association may be freely used and exchanged by the Association and shall not be subject to any restriction by the member whose currency is used or exchanged; provided that the foregoing shall not preclude the Association from entering into any arrangements with the member in whose territories any project financed by the Association is located restricting the use by the Association of such member’s currency received as principal, interest or other charges in connection with such financing.